AI assistant
Sending…
Serko Limited — Director's Dealing 2021
Jun 21, 2021
66271_rns_2021-06-22_542ae3a1-2912-4604-add6-52f11506ac20.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 29] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ToNZX Limited; and | ||||
| Name of listed issuer: | SerkoLi | mited (SKO) | ||
| Date this disclosure made: | 22-Jun- | 21 | ||
| Date of last disclosure: | 2-Jun-2 | |||
| Director or senior managergiving disclosure | ||||
| Full name(s): | Susan P | utt | ||
| Name of listed issuer: | SerkoLi | mited (SKO) | ||
| Name of related body corporate (if applicable): | N/A | |||
| Position held in listed issuer: | Former | Chief FinancialOfficer | ||
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives)Class of affected quoted financial products: | ||||
| Class of affected quoted financial products: | Ordinary | sharesinSerkoLimited | ||
| Nature of the affected relevant interest(s): | Registerofordin | |||
| ed holder and beneficial ownerary shares | ||||
| For that relevant interest- | ||||
| Number held in class before acquisition or disposal: | 360,298 | |||
| Number held in class after acquisition or disposal: | 298,298 | |||
| Current registered holder(s): | Susan P | utt | ||
| Registered holder(s)once transfers are registered: | N/A | |||
| N/A | ||||
| N/A | ||||
| The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any): | N/A | |||
| A statement as to whether the derivative is cash settled or physicallysettled: | N/A | |||
| Maturitydate of the derivative(if any): | N/A | |||
| Expirydate of the derivative(if any): | N/A | |||
| Theprice specified in the terms of the derivative(if any): | N/A | |||
| Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products: | N/A | |||
| _For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: | ||||
| Parties to the derivative: | N/A | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: | N/A | |||
| Details of transactions giving rise to acquisition or disposal | ||||
| Total number of transactions to which notice relates: | 9 |
Details of transactions requiring disclosure-
| Details of transactions requiring disclosure- | ||
|---|---|---|
| Date oftransaction: | 1. 15-Jun-212. 16-Jun-213. 17-Jun-214. 18-Jun-215. 18-Jun-216. 18-Jun-217. 18-Jun-218. 18-Jun-219. 18-Jun-21 | |
| Nature oftransaction: | On market sale of Ordinary Shares (tofund a property acquisition) | |
| Name ofany otherparty orparties to the transaction(if known): | N/A | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value, describe the consideration: | 1. $37,000 ($7.40/share)2. $7,400 ($7.40/share)3. $294,000 ($7.35/share)4. $14,680 ($7.34/share)5. $22,020 ($7.34/share)6. $14,880 ($7.44/share)7. $14,900 ($7.45/share)8. $14,980 ($7.49/share)9. $37,150 ($7.43/share)Total: $457,010 | |
| Numberof financialproducts towhichthe transaction related: | 1. 5,0002. 1,0003. 40,0004. 2,0005. 3,0006. 2,0007. 2,0008. 2,0009. 5,000Total:62,000 | |
| If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details— | ||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | N/A | |
| Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod: | N/A | |
| Date of the prior written clearance(if any): | N/A | |
| Summary of other relevant interests after acquisition or disposal:Class ofquotedfinancialproducts:Nature of relevantinterest:_For that relevant interest,- _Number heldinclass:Current registered holder(s):For a derivative relevant interest,-Type ofderivative:Details of derivative,- | ||
| N/A | ||
| N/A | ||
| N/A | ||
| N/A | ||
| N/A | ||
| The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): | N/A | |
| A statement as to whether the derivative is cash settled or physically settled: | N/A | |
| Maturity date of the derivative (if any): | N/A | |
| Expiry date of the derivative (if any): | N/A | |
| The price's specified terms (if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: | N/A | |
| For that derivative relevant interest,- | ||
| Parties to the derivative: | N/A |
N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
22-Jun-21
More from Serko Limited
Report Publication Announcement
2026
May 19
Report Publication Announcement
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 15
Share Issue/Capital Change
2026
Mar 25
Regulatory Filings
2026
Mar 9
Director's Dealing
2026
Mar 5
Major Shareholding Notification
2026
Mar 3
Major Shareholding Notification
2026
Feb 27
Major Shareholding Notification
2025
Dec 22
Investor Presentation
2025
Dec 21